Rossari Other Non Cash Items vs End Period Cash Flow Analysis

ROSSARI Stock

796.95 3.50 0.44%

Rossari Biotech financial indicator trend analysis is much more than just breaking down Rossari Biotech prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rossari Biotech is a good investment. Please check the relationship between Rossari Biotech Other Non Cash Items and its End Period Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Other Non Cash Items vs End Period Cash Flow

Other Non Cash Items vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rossari Biotech Other Non Cash Items account and End Period Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Rossari Biotech's Other Non Cash Items and End Period Cash Flow is -0.13. Overlapping area represents the amount of variation of Other Non Cash Items that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Rossari Biotech Limited, assuming nothing else is changed. The correlation between historical values of Rossari Biotech's Other Non Cash Items and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Non Cash Items of Rossari Biotech Limited are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Other Non Cash Items i.e., Rossari Biotech's Other Non Cash Items and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.13

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Non Cash Items

End Period Cash Flow

Most indicators from Rossari Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rossari Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current Tax Provision is estimated to decrease to about 316.8 M. The current Selling General Administrative is estimated to decrease to about 107.3 M

	2021	2022	2023	2024 (projected)
Interest Expense	126.6M	223.2M	193.7M	203.4M
Depreciation And Amortization	480.6M	629.3M	603.9M	320.0M

Interest Expense Depreciation And Amortization

Rossari Biotech fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets
Total Assets		0.6	0.78	0.99	0.93	0.9	0.92	1.0	0.69	0.19	0.89	0.97	0.84	0.93	0.62	0.67	0.7	0.64	0.77	0.56	0.91	0.89	0.77	0.82	0.99	1.0
Short Long Term Debt Total	0.6		0.89	0.65	0.75	0.72	0.69	0.58	0.1	0.86	0.8	0.54	0.49	0.72	0.51	0.51	0.52	0.65	0.43	0.49	0.43	0.78	0.92	0.72	0.6	0.63
Other Current Liab	0.78	0.89		0.81	0.9	0.88	0.84	0.76	0.42	0.62	0.93	0.74	0.66	0.87	0.46	0.48	0.55	0.66	0.6	0.45	0.58	0.91	1.0	0.79	0.76	0.79
Total Current Liabilities	0.99	0.65	0.81		0.93	0.9	0.91	0.99	0.63	0.25	0.9	0.97	0.82	0.92	0.62	0.69	0.68	0.66	0.77	0.55	0.88	0.89	0.81	0.83	0.99	0.99
Total Stockholder Equity	0.93	0.75	0.9	0.93		0.97	0.98	0.93	0.59	0.39	0.99	0.92	0.79	0.99	0.6	0.62	0.68	0.79	0.77	0.56	0.83	0.99	0.9	0.86	0.92	0.93
Other Liab	0.9	0.72	0.88	0.9	0.97		0.92	0.9	0.66	0.39	0.94	0.85	0.74	0.99	0.51	0.53	0.53	0.77	0.66	0.38	0.87	0.96	0.89	0.94	0.91	0.88
Net Tangible Assets	0.92	0.69	0.84	0.91	0.98	0.92		0.92	0.55	0.31	0.97	0.94	0.79	0.97	0.65	0.67	0.75	0.78	0.82	0.65	0.82	0.96	0.83	0.79	0.91	0.93
Property Plant And Equipment Net	1.0	0.58	0.76	0.99	0.93	0.9	0.92		0.67	0.18	0.89	0.97	0.79	0.93	0.57	0.64	0.65	0.69	0.76	0.52	0.91	0.89	0.76	0.8	0.99	0.99
Current Deferred Revenue	0.69	0.1	0.42	0.63	0.59	0.66	0.55	0.67		-0.34	0.49	0.6	0.78	0.64	0.32	0.22	0.43	0.12	0.43	0.21	0.78	0.49	0.39	0.63	0.69	0.63
Net Debt	0.19	0.86	0.62	0.25	0.39	0.39	0.31	0.18	-0.34		0.47	0.13	-0.03	0.35	0.12	0.18	0.06	0.56	0.06	0.1	0.03	0.48	0.67	0.42	0.19	0.22
Retained Earnings	0.89	0.8	0.93	0.9	0.99	0.94	0.97	0.89	0.49	0.47		0.9	0.73	0.97	0.58	0.62	0.66	0.81	0.77	0.56	0.75	0.99	0.93	0.82	0.88	0.91
Accounts Payable	0.97	0.54	0.74	0.97	0.92	0.85	0.94	0.97	0.6	0.13	0.9		0.8	0.91	0.64	0.74	0.72	0.68	0.86	0.61	0.86	0.88	0.73	0.73	0.96	0.98
Cash	0.84	0.49	0.66	0.82	0.79	0.74	0.79	0.79	0.78	-0.03	0.73	0.8		0.78	0.79	0.7	0.88	0.27	0.7	0.74	0.81	0.68	0.63	0.73	0.84	0.84
Non Current Assets Total	0.93	0.72	0.87	0.92	0.99	0.99	0.97	0.93	0.64	0.35	0.97	0.91	0.78		0.57	0.6	0.63	0.78	0.74	0.49	0.87	0.98	0.88	0.9	0.93	0.92
Non Currrent Assets Other	0.62	0.51	0.46	0.62	0.6	0.51	0.65	0.57	0.32	0.12	0.58	0.64	0.79	0.57		0.9	0.9	0.3	0.77	0.87	0.61	0.52	0.45	0.57	0.63	0.66
Other Assets	0.67	0.51	0.48	0.69	0.62	0.53	0.67	0.64	0.22	0.18	0.62	0.74	0.7	0.6	0.9		0.81	0.44	0.76	0.79	0.63	0.58	0.47	0.58	0.69	0.71
Cash And Short Term Investments	0.7	0.52	0.55	0.68	0.68	0.53	0.75	0.65	0.43	0.06	0.66	0.72	0.88	0.63	0.9	0.81		0.27	0.74	0.97	0.59	0.58	0.53	0.49	0.67	0.75
Net Receivables	0.64	0.65	0.66	0.66	0.79	0.77	0.78	0.69	0.12	0.56	0.81	0.68	0.27	0.78	0.3	0.44	0.27		0.57	0.24	0.58	0.86	0.7	0.65	0.65	0.64
Common Stock Shares Outstanding	0.77	0.43	0.6	0.77	0.77	0.66	0.82	0.76	0.43	0.06	0.77	0.86	0.7	0.74	0.77	0.76	0.74	0.57		0.69	0.66	0.74	0.58	0.55	0.76	0.8
Short Term Investments	0.56	0.49	0.45	0.55	0.56	0.38	0.65	0.52	0.21	0.1	0.56	0.61	0.74	0.49	0.87	0.79	0.97	0.24	0.69		0.43	0.47	0.43	0.32	0.53	0.63
Non Current Liabilities Total	0.91	0.43	0.58	0.88	0.83	0.87	0.82	0.91	0.78	0.03	0.75	0.86	0.81	0.87	0.61	0.63	0.59	0.58	0.66	0.43		0.78	0.59	0.87	0.94	0.88
Inventory	0.89	0.78	0.91	0.89	0.99	0.96	0.96	0.89	0.49	0.48	0.99	0.88	0.68	0.98	0.52	0.58	0.58	0.86	0.74	0.47	0.78		0.92	0.85	0.88	0.89
Other Current Assets	0.77	0.92	1.0	0.81	0.9	0.89	0.83	0.76	0.39	0.67	0.93	0.73	0.63	0.88	0.45	0.47	0.53	0.7	0.58	0.43	0.59	0.92		0.81	0.76	0.78
Other Stockholder Equity	0.82	0.72	0.79	0.83	0.86	0.94	0.79	0.8	0.63	0.42	0.82	0.73	0.73	0.9	0.57	0.58	0.49	0.65	0.55	0.32	0.87	0.85	0.81		0.86	0.79
Total Liab	0.99	0.6	0.76	0.99	0.92	0.91	0.91	0.99	0.69	0.19	0.88	0.96	0.84	0.93	0.63	0.69	0.67	0.65	0.76	0.53	0.94	0.88	0.76	0.86		0.98
Total Current Assets	1.0	0.63	0.79	0.99	0.93	0.88	0.93	0.99	0.63	0.22	0.91	0.98	0.84	0.92	0.66	0.71	0.75	0.64	0.8	0.63	0.88	0.89	0.78	0.79	0.98

Click cells to compare fundamentals

Rossari Biotech Account Relationship Matchups

Rossari Biotech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.7B	5.6B	12.6B	13.7B	15.7B	7.9B
Short Long Term Debt Total	45.3M	669.3M	84.3M	739.3M	1.2B	1.2B
Other Current Liab	111.1M	190.7M	157.1M	1.1B	1.3B	1.4B
Total Current Liabilities	1.5B	1.5B	2.9B	3.5B	4.2B	2.2B
Total Stockholder Equity	2.9B	4.1B	8.1B	9.2B	10.5B	11.0B
Other Liab	35.6M	21.7M	23.9M	1.6B	1.8B	1.9B
Net Tangible Assets	1.2B	2.8B	4.0B	5.4B	6.3B	6.6B
Property Plant And Equipment Net	1.1B	1.7B	3.5B	3.3B	4.3B	2.1B
Current Deferred Revenue	(329.7M)	53.9M	903.5M	1.2B	125.1M	118.8M
Net Debt	377.2M	(152.1M)	(290.5M)	41.0M	936.2M	983.0M
Retained Earnings	1.6B	2.4B	3.3B	4.4B	5.6B	5.9B
Accounts Payable	970.0M	1.3B	1.9B	1.8B	2.2B	1.4B
Cash	292.1M	152.1M	374.8M	698.3M	251.7M	254.9M
Non Current Assets Total	1.5B	2.1B	6.5B	6.5B	7.3B	7.7B
Non Currrent Assets Other	255.1M	55.9M	130.5M	183.4M	104.4M	122.5M
Other Assets	130.3M	255.6M	58.9M	144.0M	165.6M	114.4M
Cash And Short Term Investments	1.4B	883.6M	644.3M	1.5B	667.9M	732.6M
Net Receivables	941.4M	1.5B	3.0B	(23.4M)	4.3B	4.5B
Common Stock Shares Outstanding	49.3M	51.9M	55.2M	55.4M	55.3M	53.1M
Short Term Investments	1.2B	731.5M	269.5M	819.5M	416.2M	477.7M
Liabilities And Stockholders Equity	4.7B	5.6B	12.6B	13.7B	15.7B	7.9B
Non Current Liabilities Total	361.3M	23.9M	1.6B	1.1B	996.9M	568.9M
Inventory	581.7M	953.5M	1.9B	1.9B	2.8B	3.0B
Other Current Assets	290.8M	242.2M	500.8M	3.8B	4.9B	5.2B
Other Stockholder Equity	1.2B	(2.5B)	4.6B	4.6B	4.7B	4.9B
Total Liab	1.8B	1.5B	4.5B	4.5B	5.2B	2.8B
Total Current Assets	3.3B	3.5B	6.1B	7.2B	8.4B	4.4B
Short Term Debt	313.4M	53.9M	(714.9M)	390.0M	745.6M	782.9M
Intangible Assets	47.7M	107.6M	1.7B	1.5B	1.4B	1.5B
Common Stock	101.5M	103.9M	110.1M	110.3M	110.5M	91.9M
Property Plant Equipment	708.6M	1.1B	1.7B	3.5B	4.0B	4.2B
Long Term Debt	6.7M	339.6M	0.0	349.3M	333.2M	349.9M
Net Invested Capital	3.5B	4.1B	8.1B	9.9B	11.5B	6.2B
Short Long Term Debt	329.7M	0.0	84.3M	390.0M	725.0M	761.3M
Net Working Capital	1.8B	2.0B	3.1B	3.7B	4.2B	2.5B
Capital Stock	101.5M	103.9M	110.1M	110.3M	110.5M	106.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in Rossari Stock

Balance Sheet is a snapshot of the financial position of Rossari Biotech at a specified time, usually calculated after every quarter, six months, or one year. Rossari Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rossari Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rossari currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rossari Other Non Cash Items vs End Period Cash Flow Analysis

Other Non Cash Items vs End Period Cash Flow

Other Non Cash Items vs End Period Cash Flow Correlation Analysis

Correlation Coefficient

Other Non Cash Items

End Period Cash Flow

Rossari Biotech fundamental ratios Correlations

Rossari Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Rossari Biotech fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Rossari Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Other Current Assets	+ 1.0	Other Current Liab
Total Current Liabilities	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Current Liabilities